Pharma-Bio Serv (PBSV) Assets Average (2011 - 2026)

Pharma-Bio Serv (PBSV) has 14 years of Assets Average data on file, last reported at $13.6 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 15.97% year-over-year to $13.6 million; the trailing twelve-month figure through Jan 2026 stood at $13.6 million (down 15.97% YoY), and the FY2025 full-year result was $15.0 million, down 17.27% from the prior year.
• Assets Average for Q1 2026 stood at $13.6 million, roughly flat from $13.6 million in the prior quarter.
• Across five years, Assets Average topped out at $23.0 million in Q1 2022 and bottomed at $13.6 million in Q1 2026.
• The 5-year median for Assets Average is $19.6 million (2024), against an average of $18.3 million.
• The widest annual swing landed in 2022, when Assets Average fell 28.33%; it then advanced 0.67% in 2023.
• A 5-year view of Assets Average shows it stood at $20.5 million in 2022, then decreased by 1.91% to $20.1 million in 2023, then slipped by 18.88% to $16.3 million in 2024, then fell by 16.47% to $13.6 million in 2025, then decreased by 0.14% to $13.6 million in 2026.
• The last three Assets Average figures came in at $13.6 million (Q1 2026), $13.6 million (Q4 2025), and $13.7 million (Q3 2025), per Business Quant data.

Peer Comparison